| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 |
| T865455 | MACKLIN | 甲硫哒嗪盐酸盐 | ≥98% | 250元/1g; 1051元/5g; | 展开 |
|
| T792787 | MACKLIN | 甲硫哒嗪盐酸盐 | 10mM in DMSO | 620元/1ml; | 展开 |
|
| T3102 | TCI | Thioridazine Hydrochloride | >98.0%(HPLC) | 935元/5G; 3125元/25G; | 展开 |
基本信息 | 纯度/分析方法 | >98.0%(HPLC) | | 分子式/分子量 | C21H26N2S2・HCl = 407.03 | | 外观与形状(20℃) | 固体 | | 应避免的情况 | 光 | | 相关CAS RN | 50-52-2 | | Reaxys-RN | 4170703 | | PubChem物质ID | 354335117 | | Merck Index (14) | 9359 | | MDL编号 | MFCD00007620 |
技术规格 | Appearance | White to Almost white powder to crystal | | Purity(HPLC) | min. 98.0 area% | | Purity(with Total Nitrogen) | min. 95.0 % | | Melting point | 163.0 to 167.0 ℃ |
物性(参考值) | 熔点 | 165 ℃ | | 最大吸收波长 | 317(EtOH) nm |
安全信息 | 图形或危害标志 |   | | 信号词 | 警告 | | 危险性说明 | H302 : 吞咽有害。
H315 : 造成皮肤刺激。
H319 : 造成严重眼刺激。
H410 : 对水生生物毒性极大并具有长期持续影响。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。
P273 : 避免释放到环境中。
P270 : 使用本产品时不要进食、饮水或吸烟。
P264 : 作业后彻底清洗皮肤。
P280 : 戴防护手套/戴防护眼罩/戴防护面具。
P302 + P352 : 如皮肤沾染：用水充分清洗。
P391 : 收集溢出物。
P337 + P313 : 如仍觉眼刺激：求医/就诊。
P305 + P351 + P338 : 如进入眼睛：用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出，取出隐形眼镜。继续冲洗。
P362+P364 : 脱掉沾污的衣服，清洗后方可重新使用。
P332 + P313 : 如发生皮肤刺激：求医/就诊。
P301 + P312 + P330 : 如误吞咽：如感觉不适，呼叫急救中心/医生。漱口。
|
相关法规 运输信息 | UN编号 | UN3077 | | 类别 | 9 | | 包装类别 | III | | 监管条件代码(*) | |
|
| T1300000 | | Thioridazine Hydrochloride | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C21H26N2S2 · HCl | | 分子量 | 407.04 | | MDL编号 | MFCD00012655 | | PubChem化学物质编号 | 329826662 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | Cl.CSc1ccc2Sc3ccccc3N(CCC4CCCCN4C)c2c1 | | InChI | 1S/C21H26N2S2.ClH/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23;/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3;1H | | InChI key | NZFNXWQNBYZDAQ-UHFFFAOYSA-N | | Gene Information | human ... DRD2(1813), DRD3(1814), DRD4(1815), HTR2A(3356), HTR2C(3358) |
安全信息 | 象形图 | | | 警示用语： | Warning | | 危险声明 | H302 | | 预防措施声明 | P264 - P270 - P301 + P312 - P501 | | 危险分类 | Acute Tox. 4 Oral | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 |
|
| T9025 | Sigma-Aldrich | Thioridazine Hydrochloride | ≥99% | 1313.15元/5 G; 4221.4元/25 G; | 展开 |
产品说明 应用 盐酸噻哒嗪已被用作嵌入剂，使用方波伏安法(SWV)技术分析双链DNA(dsDNA)的完整性。盐酸噻哒嗪还被用作抑制人肝微粒体中肝酶细胞色素P4502D6(CYP2D6)的阳性对照。 生化/生理作用 D2 多巴胺受体拮抗剂； 吩噻嗪类抗精神病药，减少锥体束外副作用； Ca2+ 通道阻滞剂。 制备说明 250 mg盐酸硫代哒嗪可溶于5 ml水中，生成透明、无色至微黄色溶液。盐酸噻哒嗪也可溶于甲醇、乙醇和氯仿，但不溶于乙醚。 基本信息 | 经验(实验)分子式 | C21H26N2S2 · HCl | | 分子量 | 407.04 | | EC 号 | 204-992-8 | | MDL编号 | MFCD00012655 | | PubChem化学物质编号 | 57654711 | | NACRES | NA.77 |
产品性质 | 质量水平 | 100 | | 测定 | ≥99% | | 溶解性 | H2O: soluble 250 mg plus 5 ml of solvent, clear, colorless to faintly yellow
chloroform: soluble
diethyl ether: insoluble
ethanol: soluble
methanol: soluble | | SMILES string | Cl.CSc1ccc2Sc3ccccc3N(CCC4CCCCN4C)c2c1 | | InChI | 1S/C21H26N2S2.ClH/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23;/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3;1H | | InChI key | NZFNXWQNBYZDAQ-UHFFFAOYSA-N | | Gene Information | human ... DRD2(1813), DRD3(1814), DRD4(1815), HTR2A(3356), HTR2C(3358) |
安全信息 | 象形图 | | | 警示用语： | Warning | | 危险声明 | H302 | | 预防措施声明 | P264 - P270 - P301 + P312 - P501 | | 危险分类 | Acute Tox. 4 Oral | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 个人防护装备 | dust mask type N95 (US), Eyeshields, Gloves |
|
| PHR3143 | Supelco | Thioridazine Hydrochloride | pharmaceutical secondary standard, certified reference material | 2107.71元/500 mg; | 展开 |
产品说明 一般描述 Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards 分析说明 These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 附注 To see an example of a Certificate of Analysis for this material enter LRAA6959(changes by product) in the Documents slot below. This is an example certificate only and may not be the lot that you receive. 基本信息 | 经验(实验)分子式 | C21H26N2S2 · HCl | | 分子量 | 407.04 | | MDL编号 | MFCD00012655 |
产品性质 | 等级 | certified reference material
pharmaceutical secondary standard | | CofA | current certificate can be downloaded | | 包装 | pkg of 500 mg | | application(s) | pharmaceutical | | 药典可追溯性 | traceable to USP 1663008 | | 储存温度 | 2-30℃ | | SMILES string | Cl.CSc1ccc2Sc3ccccc3N(CCC4CCCCN4C)c2c1 | | InChI | 1S/C21H26N2S2.ClH/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23;/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3;1H | | InChI key | NZFNXWQNBYZDAQ-UHFFFAOYSA-N |
安全信息 | 象形图 | | | 警示用语： | Warning | | 危险声明 | H302 | | 预防措施声明 | P264 - P270 - P301 + P312 - P501 | | 危险分类 | Acute Tox. 4 Oral | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1663008 | USP | Thioridazine Hydrochloride | United States Pharmacopeia (USP) Reference Standard | 3231.47元/200 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here.
Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C21H26N2S2 · HCl | | 分子量 | 407.04 | | MDL编号 | MFCD00012655 | | PubChem化学物质编号 | 329751310 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | Cl.CSc1ccc2Sc3ccccc3N(CCC4CCCCN4C)c2c1 | | InChI | 1S/C21H26N2S2.ClH/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23;/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3;1H | | InChI key | NZFNXWQNBYZDAQ-UHFFFAOYSA-N | | Gene Information | human ... DRD2(1813), DRD3(1814), DRD4(1815), HTR2A(3356), HTR2C(3358) |
安全信息 | 象形图 | | | 警示用语： | Warning | | 危险声明 | H302 | | 预防措施声明 | P264 - P270 - P301 + P312 - P501 | | 危险分类 | Acute Tox. 4 Oral | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 |
|
m.cnreagent.com